NYSE:HIMS

Hims & Hers Health (HIMS) Stock Jumps on Policy Tailwinds and Buyback Momentum — November 24, 2025

Hims & Hers Health Inc. (NYSE: HIMS) ended Monday’s U.S. session sharply higher, extending a volatile but strongly positive year for the fast‑growing telehealth platform. Below is a news-style, SEO-optimized breakdown of Hims & Hers Health (HIMS) stock today (24.11.2025),

24 November 2025

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

HIMS Stock Today (November 18, 2025): Buyback, GLP‑1 Price War and What It Means for Hims & Hers Investors

On Tuesday, November 18, 2025, Hims & Hers Health (NYSE: HIMS) is trading in the shadow of a sharp sell‑off, a fresh $250 million share repurchase authorization, and escalating price competition in the weight‑loss drug market. Together, these forces are

18 November 2025

Buyback · GLP‑1 · Health Tech · Investor News · NYSE:HIMS · Stocks

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious.

14 November 2025

Business News · Financial Updates · Health Tech · Investments · NYSE:HIMS · Stock Market

Hims & Hers (HIMS) Stock Soars on Subscriber Surge and GLP-1 Deal Buzz – Nov 2025 Update

Current Stock Price (Nov 3, 2025) Hims & Hers Health’s stock (NYSE: HIMS) closed on Nov 3, 2025 at $44.39, down about 2.3% for the day stockanalysis.com. This modest dip came amid a broader mixed market and ahead of the

4 November 2025

Company News · Financial Analysis · Healthcare · Investing · NYSE:HIMS · Stock Market

Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Analyst outlook & forecast: Long-term, analysts model robust growth. For example, one financial model projects ~18% revenue CAGR: ~$3.3 billion in sales by 2028 and ~$261 million net income simplywall.st. Another estimate sees revenue rising from ~$2.35 B in 2025 to ~$3.34 B by

3 November 2025

Expert Opinions · Healthcare Innovation · NYSE:HIMS · Stock Market · Weight Loss · Wellness Trends

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Menopause Launch Sparks Surge in HIMS Stock Hims & Hers’ expansion into menopause care was greeted with enthusiasm in the market. On October 15, the San Francisco–based telehealth provider announced it is now offering affordable treatment plans for women in

17 October 2025

Health · Market Trends · Menopause · NYSE:HIMS · Pharmaceuticals · Weight Loss

Hims & Hers Stock Soars on New Menopause Care Expansion – What Comes Next?

Hims & Hers’ women’s health platform (Hers) now offers specialized menopause and perimenopause care investors.hims.com. The new service is aimed at improving access to hormone therapies (estradiol, progesterone, etc.) for symptoms like hot flashes and sleep issues, expanding a platform

15 October 2025

Business News · Health Tech · Investment Trends · Menopause · NYSE:HIMS · Stock Market

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

“It’s never been more clear that we are delivering exactly what millions of people have been waiting for,” said HIMS CEO Andrew Dudum after Q2 results investors.hims.com. With analysts ranging from “Sell” to “Buy”, and social media buzzing, Hims &

29 September 2025

FDA Regulation · Healthcare Stocks · Investment News · Market Trends · NYSE:HIMS · Stock Market · Weight Loss

Digital Health & Telemedicine Industry Update (June–July 2025)

In early June 2025, DispatchHealth and Medically Home completed a merger, forming one of the nation’s largest high-acuity hospital-at-home providers and operating under the DispatchHealth brand, integrating Medically Home’s virtual care technology and 24/7 clinical command centers. Teladoc Health signaled

3 July 2025

Digital Health · eHealth · Healthcare Technology · Industry Update · NASDAQ:MSFT · NYSE:HIMS · NYSE:NVO · NYSE:TDOC · Telemedicine

NYSE:HIMS News 3 July 2025 - 24 November 2025